Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer

BACKGROUND: The Khorana score is a validated tool to identify cancer patients at higher risk of venous thromboembolism (VTE). OBJECTIVE: We compared its predictive performance to that of the clinical PROTECHT and the polygenic 5‐SNP scores in patients who participated in the Dutch CPCT‐02 study. PAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Guman, Noori A. M., van Geffen, Roos J., Mulder, Frits I., van Haaps, Thijs F., Hovsepjan, Vahram, Labots, Mariette, Cirkel, Geert A., Y. F. L. de Vos, Filip, ten Tije, Albert J., Beerepoot, Laurens V., Tjan‐Heijnen, Vivianne C. G., van Laarhoven, Hanneke W. M., Hamberg, Paul, Vulink, Annelie J. E., Los, Maartje, Zwinderman, Aeilko H., Ferwerda, Bart, Lolkema, Martijn P. J. K., Steeghs, Neeltje, Büller, Harry R., Kamphuisen, Pieter W., van Es, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
THROMBOSIS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291564/
https://www.ncbi.nlm.nih.gov/pubmed/34409743
http://dx.doi.org/10.1111/jth.15503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291564/
https://www.ncbi.nlm.nih.gov/pubmed/34409743
http://dx.doi.org/10.1111/jth.15503

Ejemplares similares